Dengue Testing Market Trends

  • Report ID: 3278
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Dengue Testing Market Trends

Growth Drivers

  • Growing Incidences of Dengue-Related Infections
  • Increasing Development of Low-Cost and Reliable Dengue Testing Kits

Challenges

  • Limited Availability of Effective Diagnostic Tools in Lower Economic Regions
  • Low Per Capita Income of Population in Less-Developed Countries 

Dengue Testing Market: Key Insights

Global-Healthcare-Expenditure-per-Capita

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Base Year

2024

Forecast Year

2025-2037

CAGR

6.2%

Base Year Market Size (2024)

USD 675.22 million

Forecast Year Market Size (2037)

USD 1.47 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3278
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of dengue testing is evaluated at USD 667.34 million.

Dengue Testing Market size was over USD 635.8 million in 2023 and is poised to cross USD 1.38 billion by 2036, witnessing more than 6.2% CAGR during the forecast period i.e., between 2024-2036. The growing incidences of dengue-related infections and the development of low-cost and reliable testing kits will fuel the market growth.

Asia Pacific is poised to account for largest revenue share by 2036, owing to high prevalence of dengue virus infections in several countries of the region such as Malaysia, Philippines and Vietnam, and the increase in government expenditure on improving healthcare infrastructure along with growing emphasis on carrying out dengue awareness campaigns in the region.

The major players in the market include Abbott Laboratories, InBios International, Inc., EUROIMMUN AG, and CERTEST BIOTEC SL, among others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample